Athletic Therapeutic Pharma launches Neptune’s Proprietary MaxSimil® Ingredient

A formulation containing Neptune’s proprietary MaxSimil ingredient is now available in the sports retail channel across Canada!

Athletic Therapeutic Pharma’s (ATP) recently launched  Cholesterodefense, a total cholesterol management formula which includes plant sterol esters, Coenzyme Q10 and EPA & DHA from MaxSimil® fish oil.

It is specifically designed to target several key cardiovascular health benefits and allows health claims in Canada, such as:

  • Helps to reduce serum triglycerides
  • Helps maintain healthy cholesterol levels
  • Helps lower blood total and LDL cholesterol
  • Helps maintain/support cardiovascular health1[i].

 

MaxSimil® acts as a natural delivery system to potentially enhance the absorption of the fat-soluble ingredients present in the formula. The MaxSimil® fish oil has been clinically demonstrated with statistically significant results to be more than three (3) times better absorbed than regular fish oils2[ii].

“We are thrilled to partner with ATP, as this product launch allows for MaxSimil® to penetrate the Canadian retail market,” said François-Karl Brouillette, Vice-President Science & Innovation at Neptune. “ATP are forefront innovators who work very closely with their customers, which can also allow for Neptune to gain valuable market insights.”

 

“At ATP, we are all about quality and efficacy, and MaxSimil® is spot-on. We can eventually envision it to be included in a line of products, targeting other indications,” says Vincent Comtois, Vice-President and Cofounder of ATP.

 

 

For more information on ATP’s Cholesterodefense click here

 

 

 

 

 

 

 

 

[i] These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

 

[ii] Unpublished double-blind crossover pharmacokinetic clinical study comparing absorption of EPA+DHA